- Home
- BTO vs TLRY Comparison
BTO vs TLRY Comparison
Compare BTO & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BTO | TLRY |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 733.0M | 688.9M |
| IPO Year | 1994 | 2018 |
Fundamental Metrics
Financial Performance| Metric | BTO | TLRY |
|---|---|---|
| Price | $38.51 | $4.51 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $72.33 |
| AVG Volume (30 Days) | 38.1K | ★ 3.4M |
| Earning Date | 01-01-0001 | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.79 |
| Revenue Next Year | N/A | $19.98 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $32.01 | $0.39 |
| 52 Week High | $39.85 | $15.70 |
Technical Indicators
Market Signals| Indicator | BTO | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 61.82 | 30.46 |
| Support Level | $35.22 | $1.14 |
| Resistance Level | $39.85 | $5.71 |
| Average True Range (ATR) | 0.81 | 0.24 |
| MACD | 0.12 | -0.02 |
| Stochastic Oscillator | 82.10 | 9.52 |
Price Performance
Historical ComparisonAbout BTO John Hancock Financial Opportunities Fund
John Hancock Financial Opportunities Fund is a United States-based closed-end, diversified management investment company. Its investment objective is to provide a high level of total return consisting of long-term capital appreciation and current income. Under normal circumstances, the fund will invest at least 80% of its net assets in equity securities of U.S. and foreign financial services companies of any size. These companies may include, but are not limited to, banks, thrifts, finance and financial technology companies, brokerage and advisory firms, real estate-related firms, insurance companies, and financial holding companies.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.